PM8002 (BNT327)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PM8002 (BNT327), covering 2025-08-21 to 2025-08-21. Get the full timeline:
Most recent: Clinical Trial Update: PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer [Phase 2]